U.S. Biotech Stocks

Viatris

Market Cap: US$9.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Medpace Holdings

Market Cap: US$9.2b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Qiagen

Market Cap: US$9.0b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Bio-Techne

Market Cap: US$8.5b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Exact Sciences

Market Cap: US$8.5b

Provides cancer screening and diagnostic test products in the United States and internationally.

Bio-Rad Laboratories

Market Cap: US$7.8b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Corcept Therapeutics

Market Cap: US$7.7b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Halozyme Therapeutics

Market Cap: US$7.5b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Roivant Sciences

Market Cap: US$7.1b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.

Repligen

Market Cap: US$7.0b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Madrigal Pharmaceuticals

Market Cap: US$6.9b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Charles River Laboratories International

Market Cap: US$6.8b

Charles River Laboratories International, Inc.

Jazz Pharmaceuticals

Market Cap: US$6.7b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Revolution Medicines

Market Cap: US$6.5b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Bruker

Market Cap: US$6.2b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Legend Biotech

Market Cap: US$5.9b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Stevanato Group

Market Cap: US$5.6b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Sarepta Therapeutics

Market Cap: US$5.4b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Blueprint Medicines

Market Cap: US$5.2b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

TG Therapeutics

Market Cap: US$5.2b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Axsome Therapeutics

Market Cap: US$5.0b

A biopharmaceutical company, engages in developing and delivering novel therapies for the management of central nervous system (CNS) disorders in the United States.

Verona Pharma

Market Cap: US$4.9b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

Krystal Biotech

Market Cap: US$4.8b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Alkermes

Market Cap: US$4.7b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Nuvalent

Market Cap: US$4.6b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

ADMA Biologics

Market Cap: US$4.6b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Cytokinetics

Market Cap: US$4.4b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Ionis Pharmaceuticals

Market Cap: US$4.4b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Prestige Consumer Healthcare

Market Cap: US$4.1b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Vaxcyte

Market Cap: US$4.0b

A clinical-stage biotechnology vaccine company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Rhythm Pharmaceuticals

Market Cap: US$3.8b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Perrigo

Market Cap: US$3.5b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Arcellx

Market Cap: US$3.3b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Sotera Health

Market Cap: US$3.2b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Ultragenyx Pharmaceutical

Market Cap: US$3.1b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

CRISPR Therapeutics

Market Cap: US$3.0b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.